The antibiotics sector needs a revitalizing shot. The U.S. government's response to COVID may hold some answers.
The Trump administration has given Kodak hundreds of millions of dollars to produce chemicals for COVID-19 treatments. But the venerable photography company will have to compete with a global supply chain.
What does it mean for the rest of the world if countries have dibs on vaccine doses?
China plays a big part in the supply chain of Americans' generic drugs
Some experts doubt that the rule would have been capable of lowering drug prices.
Industry analysts expect the price for the single-treatment therapy to be anywhere from $1.5 million to $5 million.
The idea is that transparency would lead to more competition and lower costs. One drug company is already on board.
Pharmacy chain Walgreens reported a 3.8 percent drop in sales for the quarter. The company cited a weak cough, cold and flu season — and declining profits from generic and branded prescription drugs. Click the audio player above to hear the full story.
The Food and Drug Administration has approved the first new kind of drug to treat depression since Prozac hit the scene in the late 1980s. Spravato is a nasal spray from Johnson & Johnson that’s a close cousin of ketamine, an anesthetic that’s sometimes used recreationally and often known as “Special K.” Because ketamine can cause […]
Drug companies can get creative with doctor incentives, and that can be problematic.